Similarly, Vairaktaris et al. found that the MMP1 -1607 1G>2G polymorphism was associated with a decreased risk of oral cancer in 2G allele carriers in a European population [21]. The gene discussed is MMP1; the disease is lip and oral cavity carcinoma.